
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
GENERAL COMMENTARY article
Front. Pharmacol. , 08 April 2016
Sec. Drugs Outcomes Research and Policies
Volume 7 - 2016 | https://doi.org/10.3389/fphar.2016.00062
This article is a commentary on:
Water hyacinth: a possible alternative rate retarding natural polymer used in sustained release tablet design
An expression of concern on
Water hyacinth: a possible alternative rate retarding natural polymer used in sustained release tablet design
by Khatun, S., and Sutradhar, K. B. (2014). Front. Pharmacol. 5:137. doi: 10.3389/fphar.2014.00137
With this notice, we alert readers that Frontiers has received two messages questioning the soundness of the experimental results of the publication “Water hyacinth: a possible alternative rate retarding natural polymer used in sustained release tablet design” published on 11 June 2014 in Frontiers in Pharmacology. Our Chief Editors, Prof. Theophile Godfraind and Dr. Dominique Dubois, will direct an investigation in full accordance with our procedures and with the collaboration of the authors. The situation will be updated as soon as the investigation is complete.
Citation: Frontiers in Pharmacology Editorial Office (2016) Expression of Concern: Water hyacinth: a possible alternative rate retarding natural polymer used in sustained release tablet design. Front. Pharmacol. 7:62. doi: 10.3389/fphar.2016.00062
Received: 25 February 2016; Accepted: 04 March 2016;
Published: 08 April 2016.
Edited and reviewed by: Dominique J. Dubois, Université Libre de Bruxelles, Belgium
Copyright © 2016 Frontiers in Pharmacology Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers in Pharmacology Editorial Office, cGhhcm1hY29sb2d5LmVkaXRvcmlhbC5vZmZpY2VAZnJvbnRpZXJzaW4ub3Jn
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.